The ongoing evolution of SARS-CoV-2 into more easily transmissible and infectious variants has sparked concern over the continued effectiveness of existing vaccines and therapeutic antibodies. Together with increased genomic surveillance, methods to rapidly develop and assess effective interventions are critically needed. We recently developed methods to
characterize spike mutations emerging in variants of concern (VOCs) using mammalian synthetic biology and developed technologies for the rapid discovery of potent SARS-CoV-2 neutralizing antibodies from previously infected patients. These strategies should prove broadly applicable in interrogating adaptive immunity and in developing rapid-response biological countermeasures to emerging pathogens.
This seminar will also be streamed online via MS Teams.
Microsoft Teams meeting
Join on your computer or mobile app
Or call in (audio only)
+1 832-856-3689,,180306029# United States, Houston
Phone Conference ID: 180 306 029#
Thursday, June 16 at 12:00pm to 1:00pm
Houston Methodist Research Institute, Ernest H. Cockrell Boardroom R2-311
6670 Bertner Avenue